Effectiveness of individualized homoeopathic medicines versus Oophorinum in polycystic ovarian syndrome (PCOS): An open-label randomized pragmatic clinical trial

ational Institute of Homoeopathy Ministry of AYUSH Govt of India0 个研究点目标入组 64 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Diagnosed PCOS as per Rotterdam diagnostic criteria
•2. Age 18-45 years
•3. Symptomatic for at least last 3 months
•4. Patients taking oral contraceptive pills (OCPs) will be advised to stop pills till it exhaust for the ongoing cycle, followed by re-assessment of symptoms in the next cycle enrolment
•5. Patients under hormonal replacement therapy (HRT) to be included after a washout period of 3 months
•6. Ability to read Bengali
•8. Patients giving written consent to participate

•1. Unevaluated gynaecological abnormalities; e.g. unexplained vaginal bleeding, cervical dysplasia, pelvic inflammatory diseases (PID) within one month, patients with suspicious adenomyosis, gross developmental defect or congenital abnormalities of the uterus etc.
•2. Genito-urinary tract malignancy
•3. Patients desiring immediate surgical management for PCOS
•4. Patients insisting to use OCPs
•5. Patients with psychiatric diseases
•6. Pregnancy and lactation
•7. Cases suffering from uncontrolled systemic illness or life-threatening infections or any vital organ failure
•8. Cases already undergoing homoeopathic treatment for any chronic disease
•9. Substance abuse and/or dependence
•10. Self-reported immune-compromised state

发起方

ational Institute of Homoeopathy Ministry of AYUSH Govt of India